| A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction T Sato, S Verma, CDC Andrade, M Omeara, N Campbell, JS Wang, ... Nature communications 11 (1), 3282, 2020 | 80 | 2020 |
| Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin JS Wang, T Kamath, CM Mazur, F Mirzamohammadi, D Rotter, H Hojo, ... Nature communications 12 (1), 6271, 2021 | 74 | 2021 |
| Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling S Nishimori, MJ O’Meara, CD Castro, H Noda, M Cetinbas, ... The Journal of Clinical Investigation 129 (12), 5187-5203, 2019 | 41 | 2019 |
| Structure-based design of selective, orally available salt-inducible kinase inhibitors that stimulate bone formation in mice T Sato, CDC Andrade, SH Yoon, Y Zhao, WJ Greenlee, PC Weber, ... Proceedings of the National Academy of Sciences 119 (50), e2214396119, 2022 | 21 | 2022 |
| A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis SH Yoon, MB Meyer, C Arevalo, M Tekguc, C Zhang, JS Wang, ... The Journal of clinical investigation 133 (9), 2023 | 20 | 2023 |
| Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption CC Tang, CD Castro Andrade, MJ O'Meara, SH Yoon, T Sato, DJ Brooks, ... Elife 10, e67772, 2021 | 20 | 2021 |
| Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy CM Mazur, CDC Andrade, N Tokavanich, T Sato, M Bruce, DJ Brooks, ... Iscience 25 (9), 2022 | 7 | 2022 |
| Bone anabolic effects of a novel, orally-available salt inducible kinase inhibitor T Sato, CD Andrade, DJ Brooks, ML Bouxsein, Y Zhao, B Lanske, ... JOURNAL OF BONE AND MINERAL RESEARCH 37, 350-350, 2022 | 1 | 2022 |
| Increased bone mass, bone formation, and bone resorption caused by adult onset compound deletion of Sik2 and Sik3 in mice CCK Tang, CDC Andrade, DJ Brooks, ML Bouxsein, J da Silva Martins, ... Annual Meeting of the American-Society-for-Bone-and Mineral Research (ASBMR …, 2020 | 1 | 2020 |
| Trafficking and translation of mRNA in osteocyte dendrites CM Mazur, PE Kotsalidis, CDC Andrade, M Wu, X Wang, M Taliaferro, ... bioRxiv, 2024.10. 01.616162, 2024 | | 2024 |
| Partial prevention of glucocorticoid-induced osteocyte deterioration with osteocrin gene therapy CM Mazur, CD Castro Andrade, T Sato, M Bruce, ML Bouxsein, JS Wang, ... bioRxiv, 2021.11. 19.469265, 2021 | | 2021 |
| Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin T Kamath, DJ Brooks, A Abdul, H Hojo, T Enishi, F Mirzamohammadi, ... (No Title), 2021 | | 2021 |
| Mass Cytometry Reveals Rare Bone Marrow Stromal Cell Populations Targeted by Abaloparatide and Teriparatide M Wein, C Castro, C Janton, D Balani, H Kronenberg, N Severe, ... JOURNAL OF BONE AND MINERAL RESEARCH 34, 288-289, 2019 | | 2019 |
| Molecular concordance between the skeletal effects of PTH1RH223R overexpression and deletion of salt inducible kinases 2 and 3 C Castro, M Omeara, JS Martins, D Brooks, M Bruce, M Bouxsein, ... JOURNAL OF BONE AND MINERAL RESEARCH 34, 10-10, 2019 | | 2019 |
| A Novel SP7/OSTN Axis Controls Osteocyte Morphology and Function JS Wang, F Mirzamohammadi, D Rotter, CDC Andrade, HM Kronenberg, ... JOURNAL OF BONE AND MINERAL RESEARCH 34, 37-37, 2019 | | 2019 |
Daniel J BrooksSenior Research Associate, Beth Israel Deaconess Medical CenterAdresse e-mail validée de bidmc.harvard.edu
